Lawrence Weiss - Dec 2, 2024 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role: SVP, Chief Legal Officer
Signature: /s/ Lawrence Weiss
Stock symbol: ANGO
Transactions as of: Dec 2, 2024
Transactions value $: $0
Form type: 4
Date filed: 12/4/2024, 09:33 PM
Previous filing: Jul 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANGO	Common Stock	Award	$0	+52.7K		$0.00	52.7K	Dec 2, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANGO	Non-Qualified Stock Option (right to buy)	Award	$0	+104K		$0.00	104K	Dec 2, 2024	Common Stock	104K	$7.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The acquisition of 52,697 shares of common stock ("Common Stock") of AngioDynamics, Inc.("AngioDynamics") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028.
F2	These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028.

Content

The acquisition of 52,697 shares of common stock ("Common Stock") of AngioDynamics, Inc.("AngioDynamics") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028.

These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028.